JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Appointment of Company Secretary and Compliance Officer
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that Mr. Abhishek Joshi has been appointed as Company Secretary and Compliance Officer of the Company w.e.f. February 13, 2023. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith Press release along with investor presentation for the quarter and nine months ended 31.12.2022. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2022.
Please find enclosed Unaudited financial results for the quarter and nine months ended 31.12.2022. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Results For The Quarter And Nine Months Ended 31St Dec, 2022.
Unaudited financial results quarter and nine months ended 31st dec, 2022. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for Intimation For Board Meeting To Discuss 3Rd Quarter Results Quarter Ended 31-12-2022.
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that a Meeting of Board of Directors of the Company will be held on Wednesday, February 8, 2023, inter alia, to consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended December 31, 2022. As per the provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company was closed on January 1, 2023 and will remain closed until February 10, 2023. This is for your information purposes. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window
Closing of trading window for the quarter ended 31 December, 2022. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulations, (Amendments) 2018.
Pursuant to Regulation 23(9) of the SEBI Listing Regulations, please find enclosed herewith disclosures of related party transactions on consolidated basis in the revised format, as prescribed under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22" November 2021, for the half year ended commencing from 01 April, 2022 to 30 September, 2022. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for financial results for the quarter and half year ended 30th September, 2022.